ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

1ORNBV Orion Corporation

36.97
0.00 (0.00%)
10 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Orion Corporation 1ORNBV Italy Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 36.97 08:43:04
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
36.97
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/5/202400:30GLOBEOrion Corporation: Change in Orion Group Executive..
06/5/202404:00GLOBEOrion Corporation: Managers’ transactions – Karen Lykke..
26/4/202408:00GLOBEOrion Corporation: Disclosure Under Chapter 9 Section 10 of..
26/4/202403:15GLOBEComposition of the Nomination Committee of Orion Corporation
25/4/202408:30GLOBEOrion Corporation: Disclosure Under Chapter 9 Section 10 of..
25/4/202404:00GLOBEOrion Group Interim Report January–March 2024
22/4/202401:45GLOBEOrion Corporation: Managers’ transactions – Veli-Matti..
11/4/202401:30GLOBEOrion publishes Interim Report for January–March 2024 and..
22/3/202405:30GLOBEChange in Orion Group Executive Management Board: change in..
22/3/202405:00GLOBEThe change negotiations concerning Orion’s Kuopio plant have..
20/3/202410:00UKREGOrion Corporation: Organising meeting of the Board of..
20/3/202409:50UKREGDecisions taken by Orion Corporation’s Annual General..
04/3/202405:00GLOBEOrion Corporation: Managers’ transactions – Olli Huotari
01/3/202410:50GLOBEOrion Corporation: Transfer of 150,118 own B shares on 1..
26/2/202406:30GLOBEOrion Group Financial Statement documents 2023, Corporate..
22/2/202403:00GLOBEOrion and Save the Children Finland announce cooperation to..
19/2/202405:15GLOBEOrion to investigate the possible outsourcing of its..
13/2/202404:15GLOBENotice to the Annual General Meeting of Orion Corporation
13/2/202404:00GLOBEOrion Group Financial Statement Release January–December..
07/2/202401:30GLOBE119,021 Orion Corporation A shares converted into B shares
29/1/202407:00GLOBEOrion publishes Financial Statement Release for 2023 and..
29/1/202403:00GLOBEOrion Corporation and Newel Health enter into licensing..
26/1/202401:00GLOBEAdditional ODM-208/MK-5684 Phase II data presented at..
23/1/202401:00GLOBEChange in Orion Group Executive Management Board – René..
11/1/202408:50GLOBERecommendation by the Orion Nomination Committee on the..
11/1/202406:15GLOBEInsurance portfolio of Orion Pension Fund’s B fund..
08/1/202403:00GLOBEOrion Corporation: Managers’ transactions – Ari Lehtoranta
08/1/202401:00GLOBEOrion and Glykos announce research collaboration and..
05/1/202405:45GLOBEOrion and MSD Announce Initiation of Two Phase 3 Trials..
27/12/202303:00GLOBENEJM Evidence publishes results from Phase I/IIa CYPIDES..
04/12/202301:45GLOBE87 000 Orion Corporation A shares converted into B shares
21/11/202300:30GLOBEPhase 3 Clinical Trials with ODM-208 (MK-5684) posted to..
20/11/202307:00GLOBEOrion Animal Health receives FDA approval for Bonqat®..
16/11/202302:15GLOBEOrion Corporation: Managers’ transactions – Agendum Oy
15/11/202301:00GLOBEOrion Research Foundation grants EUR 1,112,000 for research..

Su Consulta Reciente

Delayed Upgrade Clock